Employees Retirement System of Texas’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Employees Retirement System of Texas’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-148,500	Closed	-$1.71M	–	1008
2014 Q3	$1.71M	Hold	148,500	–	–	0.02%	666
2014 Q2	$2.89M	Hold	148,500	–	–	0.04%	516
2014 Q1	$2.66M	Hold	148,500	–	–	0.04%	506
2013 Q4	$1.57M	Buy	148,500 +88,500	+148%	+$989K	0.02%	728
2013 Q3	$742K	Buy	+60,000	New	+$632K	0.01%	958

Other funds holding CASC

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Employees Retirement System of Texas's CASC Position: Q4 2014 in Review

Employees Retirement System of Texas sold out of Cascadian Therapeutics, Inc. (CASC) in Q4 2014, closing a stake of 148,500 shares — an estimated $1.71M sold.

Employees Retirement System of Texas first reported a position in CASC in Q3 2013 and held it in 5 quarters. The position peaked at $2.89M in Q2 2014. 86 funds tracked by Wall St. Rank hold CASC as of Q4 2014.

Employees Retirement System of Texas reported no remaining Cascadian Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
Employees Retirement System of Texas sold 148,500 Cascadian Therapeutics, Inc. shares in Q4 2014, an estimated $1.71M.
Employees Retirement System of Texas first reported a position in Cascadian Therapeutics, Inc. in Q3 2013 and held it in 5 quarters.
Employees Retirement System of Texas's Cascadian Therapeutics, Inc. position peaked at $2.89M in Q2 2014.
86 funds tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q4 2014.

Based on Employees Retirement System of Texas's 13F filing for Q4 2014, filed 9 Feb 2015.